In fact, AML patients with PML/RARα are curable with a combination of arsenic trioxide (As2O3) and all-trans retinoic acid (ATRA), which have shown higher success rates compared with other AML subtypes [9]. The gene discussed is PML; the disease is acute myeloid leukemia.